Forge Biologics to Present at 2021 Cell & Gene Meeting on the Mesa

Oct. 11, 2021 12:00 UTC


CEO to discuss company’s AAV gene therapy manufacturing and company achievements over the past 12 months


COLUMBUS, Ohio--(BUSINESS WIRE)-- Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today that Timothy J. Miller, Ph.D., CEO, President and Co-Founder, will discuss Forge’s robust AAV manufacturing solutions, proprietary technology advancements, and clinical development during a company presentation at Cell & Gene Meeting on the Mesa on October 12 at 5:00 p.m. PT.

Dr. Miller will also join a panel of gene therapy experts for a discussion on “Dosing & Redosing in Gene Therapy,” October 14 at 11:00 a.m. PT.

The conference will take place October 12-14, 2021, at the Park Hyatt Aviara, in Carlsbad, California. To learn more about the event and registration, please visit:

Forge will be taking meetings during Meeting on the Mesa. Please contact John Maslowski, Chief Commercial Officer, at if you are interested in connecting and learning more about how Forge’s manufacturing solutions can support your gene therapy program.

About Forge Biologics

Forge Biologics is a hybrid gene therapy contract manufacturing and therapeutics development company. Forge’s mission is to enable access to life changing gene therapies and help bring them from idea to reality. Forge has a 175,000 square foot facility in Columbus, Ohio, The Hearth, to serve as its headquarters. The Hearth is a custom-designed cGMP facility dedicated to AAV vector manufacturing and will host end-to-end manufacturing services to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. By taking a patients-first approach, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most. To learn more, visit


Media Inquiries
Marina Corleto
Senior Manager, Marketing and Communications

Families and Clinician Inquiries
Dr. Maria Escolar
Chief Medical Officer

Business Development
Magdalena Tyrpien
Vice President, Head of Business Development

Client Development
John Maslowski
Chief Commercial Officer

Investor Relations
Christina Perry, MSA, CPA
Vice President, Finance and Investor Relations


Source: Forge Biologics

Back to news